---
figid: PMC9374466__IJO-61-3-05400-g02
pmcid: PMC9374466
image_filename: IJO-61-3-05400-g02.jpg
figure_link: /pmc/articles/PMC9374466/figure/f3-ijo-61-3-05400/
number: Figure 3
figure_title: ''
caption: CASC11 promotes migration of PCa cells. (A-C) CASC11 knockdown attenuated
  cell migration in LNCaP cells, whereas CASC11 overexpression exerted the opposite
  effect. (D-F) CASC11 knockdown attenuated cell migration in 22Rv1 cells, whereas
  CASC11 overexpression exerted the opposite effect. (G and H) Transwell assay demonstrated
  that CASC11 knockdown inhibited cell migration in LNCaP and 22Rv1 cells. (I and
  J) Transwell assay demonstrated that CASC11 overexpression promoted cell migration
  in LNCaP and 22Rv1 cells. Scale bar, 100 Âµm. *P<0.05, **P<0.01 vs. sh-NC or vector.
  CASC11, cancer susceptibility candidate 11; NC, negative control; OE-CASC11, CASC11
  overexpression plasmid; PCa, prostate cancer; sh, short hairpin.
article_title: Long non-coding RNA CASC11 interacts with YBX1 to promote prostate
  cancer progression by suppressing the p53 pathway.
citation: Xianchao Sun, et al. Int J Oncol. 2022 Sep;61(3):110.
year: '2022'

doi: 10.3892/ijo.2022.5400
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos

keywords:
- prostate cancer
- CASC11
- Y-box binding protein 1
- p53 pathway
- progression

---
